1. Home
  2. LXRX vs RPT Comparison

LXRX vs RPT Comparison

Compare LXRX & RPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • RPT
  • Stock Information
  • Founded
  • LXRX 1995
  • RPT 2014
  • Country
  • LXRX United States
  • RPT United States
  • Employees
  • LXRX N/A
  • RPT N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • RPT
  • Sector
  • LXRX Health Care
  • RPT
  • Exchange
  • LXRX Nasdaq
  • RPT NYSE
  • Market Cap
  • LXRX 124.4M
  • RPT 120.1M
  • IPO Year
  • LXRX 2000
  • RPT N/A
  • Fundamental
  • Price
  • LXRX $0.51
  • RPT $2.59
  • Analyst Decision
  • LXRX Buy
  • RPT Strong Buy
  • Analyst Count
  • LXRX 4
  • RPT 1
  • Target Price
  • LXRX $3.67
  • RPT $4.00
  • AVG Volume (30 Days)
  • LXRX 32.2M
  • RPT 254.0K
  • Earning Date
  • LXRX 05-01-2025
  • RPT 04-28-2025
  • Dividend Yield
  • LXRX N/A
  • RPT 9.23%
  • EPS Growth
  • LXRX N/A
  • RPT N/A
  • EPS
  • LXRX N/A
  • RPT N/A
  • Revenue
  • LXRX $31,081,000.00
  • RPT N/A
  • Revenue This Year
  • LXRX N/A
  • RPT N/A
  • Revenue Next Year
  • LXRX $63.36
  • RPT N/A
  • P/E Ratio
  • LXRX N/A
  • RPT N/A
  • Revenue Growth
  • LXRX 2481.48
  • RPT N/A
  • 52 Week Low
  • LXRX $0.28
  • RPT $2.29
  • 52 Week High
  • LXRX $2.45
  • RPT $3.86
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 53.30
  • RPT N/A
  • Support Level
  • LXRX $0.48
  • RPT N/A
  • Resistance Level
  • LXRX $0.60
  • RPT N/A
  • Average True Range (ATR)
  • LXRX 0.09
  • RPT 0.00
  • MACD
  • LXRX 0.01
  • RPT 0.00
  • Stochastic Oscillator
  • LXRX 42.86
  • RPT 0.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About RPT RITHM PROPERTY TRUST INC

Rithm Property Trust Inc is a real estate investment trust (REIT) externally managed by an affiliate of Rithm Capital Corp. (Rithm). The group is embarking on a new commercial real estate-focused investment. Its tailored approach to investment management seeks to generate attractive risk-adjusted returns for stockholders over the long term through dividends and capital appreciation.

Share on Social Networks: